Moderna's COVID-19 Vaccine is Nearly 95 Effective
The Claim
Moderna has launched a new COVID-19 vaccination that’s nearly 95% effective.
Emerging story
On November 16, 2020, a Twitter user posted: “Moderna’s COVID-19 vaccine: 94.5% effective against virus, No significant safety concerns, 30,000 trail participants and analysis based on 95 cases…” This post was in response to information on the Moderna vaccine being rated as 94.5% effective against COVID-19.
The post received 2.6K likes and several retweets from other users.
Misbar’s Analysis
Misbar finds this claim to be true – Morena has indeed released a new vaccination that is currently being researched and analyzed by scientists.
COVID-19 has taken the world by storm, infecting more than 55.6M people across the world with 11.4M in the United States. Recently, in hopes of minimizing the impact, Morena has launched a vaccine that is said to be 94.5% effective against the virus.
This vaccination can be compared against the Pfizer vaccination, another vaccine that has been released for the same virus.
Both vaccines leverage new innovative methods of kicking off immune system reactions to the infection using mRNA. Pfizer’s vaccine is believed to have temperature storing requirements of minus 70 degrees Celsius, and Morena at minus 20 degree Celsius. While they have varying temperature requirements, they both present solutions to COVID-19 infection. These temperature requirements will require different vaccination methods and distribution mechanisms. However, whereas the Morena vaccine is 94.5% effective, Pfizer’s vaccine is slightly more than 90% effective.
As more evaluations are conducted, the effectiveness and long-term effects of these vaccinations will be analyzed to further draw conclusions on the benefits of these solutions.
